<?xml version="1.0" encoding="UTF-8"?>
<ref id="B78-viruses-12-00526">
 <label>78.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cai</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Shu</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Liao</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Gu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Cai</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study</article-title>
  <source>Engineering</source>
  <year>2020</year>
  <comment>in press</comment>
  <pub-id pub-id-type="doi">10.1016/j.eng.2020.03.007</pub-id>
 </element-citation>
</ref>
